We all need to be patient with Cytodyn and the route they

New Post Public Reply Private Reply Replies (2) Message Board
Rbarb100
1,457
We all need to be patient with Cytodyn and the route they are taking. A lot is not totally in their control but they keep pushing forward even though once in a while they hit a road.

"The race is not given to the swift nor the strong but he who endures until the end." (Ecclesiastes 9:11)

Dr. Bruce K. Patterson is a scientist who is fully in support of leronlimab and continues to talk out on support of leronlimab. Incelldx's relationship has cool off for quite some time but Dr. Patterson has and will continue to promote leronlimab. He did so in his fantastic TedTalk on June 17, 2020 and he will do so this Monday evening in his talk with Dr. Been. Also remember that Dr. Patterson had indicated that does not own any stock in Cytodyn.

Also remember that Dr. Pourhassan is the CEO but he reports to the Board of Directors and the Board is involved and consulted with on major decisions. Also the Chairman of the Board, Dr. Scott Kelly, is the largest individual shareholder in Cytodyn, having over 10 million shares. In the few conference calls that I have seen Dr. Kelly he appears to be a very smart, no nonsense medical doctor who provides alot of insight into the medical side of Cytodyn.

Dr.Kelly is also involved with and understands all the medical processes that Cytodyn is trying to use to cure the many medical issues that exists.
Dr. Pourhassen indicated that Dr.Kelly is involved in attracting top notch doctors in various medical fields that Cytodyn is in to become, I believe, special consultants.

The information for the HIV Bla is being worked on and will be eventually provided to the Fda. Nader voluntarily provided the information to us of what the Fda asked in their Request for Evidence, which is not a rejection. The Fda has been involved with Cytodyn for quite awhile in their rolling review and this process will continue forward. It is better to make sure that Cytodyn provides solid response to the Fda so that we can get clearance from the Fda and receive a positive Pdufa date. I am hoping for a date 6 months from May 11-12, but I am not sure when the clock will start running on the Pdufa date.

With respect to foreign countries it is unfortunate about the delay with the nondisclosure agreement but the agreement has or will be signed shortly and the small 25 patient test can proceed. Mexico has a very serious coronavirus situation and should have enough patients to immediately commence and complete the phase III trial. A mexican Fda approval will be great for Cytodyn but also for the citizens of Mexico. Hopefully Brazil is moving forward with Cytodyn because of Brazil's horrific corona virus problem.

We also have Dr. Been who, I think, is now a believer in Cytodyn. By now he has thoroughly investigated leronlimab and has become a supporter of it. Hopefully he has reached out to India and Pakistan about leronlimab. It was great to see over 1200 people at the youtube conference call last night.

Dr. Yo is another medical doctor that is supportive of Cytodyn and leronlimab. And he has recently disclosed that he has purchased stock in Cytodyn. Dr.Yo is well respected and has a huge following. I believe Dr.Yo will be on Dr. Drew's show on Tuesday afternoon to discuss leronlimab and another drug and covid. He continues to get the word out.

We have also filed for uplisting on the Nasdaq. The process normally takes 4-6 weeks to process but it can be quicker. CFO Mulholland had been working on the uplisting since early June so the uplisting petition should be in good shape. We should receive a response hopefully by the end of July, beginning of August. A response on the uplisting should occur before we hear back from the Fda on our mild to moderate submission since we probably won't complete the information needed to be submitted to the Fda until late this week or the following week. Hopefully the other information for the Fda on the HIV Bla can and is submitted this week.

Approval to the Nasdaq will be wonderful. At that time large institutions can then purchase the stock. It will also help us with the short sellers because of the Nasdaq triggering mechanism that stops trading in a stock if a stock drops too much in process.

Again patience is a virtue with Cytodyn. The stock should go up as it has over the past 10 months. From 30 cents to over $ 5 and recently hitting a high of $10. But his is nothing if we continue to move forward. It has happened to companies like Novavax that went from $5 to over $140 and Moderna that went from the teens to over $90.

Keep the faith and the patience as Cytodyn continues to march forward. Hold the stock (buy more) if you are a believer. Covid19 is a problem that we know that Cytodyn can help with and we know that the company's focus is to get approval from the Fda as quickly as possible. A quick approval will help to deal with people who have attracted the covid virus while big pharma and other biomedical companies (such as Generex) work on a vaccine.

Looking forward to a very interesting week and the days and months ahead!


CytoDyn Inc (CYDY) Stock Research Links

CYDY Board Company Profile Buy Rating Time & Sales News Filings Financials
Scroll down for more posts ▼

Top 10 Most Recent News Articles

Battery Testing Market to Reach $45 Billion by 2033

Updated Category News Views 15

There's a gold rush happening in the battery testing market, as ambitious as any I've seen in my trading years. The market's taking off faster than a Wall Street trader on a bull market open, projected to skyrocket from $13.03 billion in 2026 to $45.06 billion by 2033. That's a hefty 19.4% compound annual growth rate, a pace that'll have big money and new players...

Continue Reading
Aura Shakes Up Q3 with AI Innovations and Revenue Boost

Updated Category News Views 122

You ever want to see a company not just keep pace but actually lead the dance? That's Aura for you—and they're quite the partner this quarter. Revenue's jumped up by a neat 24% in Q3 2026, ringing in at $87.9 million. If there's one thing investors can't turn a blind eye to, it's numbers like that. All that amid Aura's new strides into the AI frontier, spearheaded by...

Continue Reading
Housing Markets Realign: Shifting Generational Burdens

Updated Category News Views 27

Riding the Generational Equity Wave Here's a kicker for you—the housing game has warped in ways that have flummoxed even the sharpest minds nodding along at economic seminars. Elder millennials back in the early 30s bracket once rode high with those mythical low mortgage rates—magic numbers scratching the underbelly of 3%, if you can believe it. But in today's...

Continue Reading
Webull Faces Class Action Over China Ties Missteps

Updated Category News Views 137

What's Brewing with Webull? Troubling allegations have bubbled to the surface regarding Webull Corporation, now in the crosshairs of a securities class action. The heart of this legal storm is the claim that Webull, under the ticker NASDAQ:BULL, allegedly disguised its deep-seated ties with China. And boy, when those revelations hit the news on October 7, 2026, it sent...

Continue Reading
Tuya Debuts Skill for Meta Muse: Smart Home Mastery

Updated Category News Views 16

Connecting the Dots in Smart Homes You ever find yourself fiddling around with three remotes to dim the lights and crank up the thermostat? I reckon you're not alone. Well, Tuya Smart just threw a curveball into the mix. They've teamed up with Meta's Muse to create Tuya Cloud Devices, an open-source Skill that's designed to let folks control their smart home tech with...

Continue Reading
How to Assess a True Christian School Experience

Updated Category News Views 60

Making the Right Spiritual Choice for Your Kids Deciding on a Christian school isn't just about academics or facilities—it’s a spiritual journey that shapes your child's worldview and relationship with God. In Kearney, Nebraska, where strong Christian values are prevalent, Anthony Splittgerber of Zion Lutheran School breaks down for HelloNation how faith-based...

Continue Reading
LiuGong Pushes Sustainability at 2026 Dealer Conference

Updated Category News Views 25

The Road to Green: LiuGong’s Ambitious Vision In a world where more heads are turning towards sustainability, LiuGong stepped up and showcased its green aspirations with flare at the 2026 Global Dealer Conference held from November 10 to 12 in Liuzhou, China. Over 2,000 attendees, ranging from dealers to customers, were in attendance to witness what seemed to be both a...

Continue Reading
Water Wings Swim School Splashes into Billings

Updated Category News Views 122

Billings Dives into the Swim School Scene Well, folks, Billings is about to get its feet wet with something new and well-needed in the local scene. Come November 21, Montana will welcome its first dedicated swim school as Water Wings opens shop right here in Billings at 2618 King Ave W. This ain't just run-of-the-mill comic relief on disaster-preparedness. We're talking...

Continue Reading
GAMG Strengthens Shareholder Services with Transition

Updated Category News Views 51

Tech Upgrade for GAMG's Operations Hard to believe it's taken this long, but Global Asset Management Group (OTCQB: GAMG) has finally updated their playbook, folks. With its recent switch to Transfer Online as their new transfer agent, we've got ourselves a company stepping up its infrastructure game. This isn't just a run-of-the-mill shift—this move represents a...

Continue Reading
Azazie Pops Up in Citrus Fields with Bridal Bliss

Updated Category News Views 83

Azazie Steps into the Sunshine State Alright, here we go—Azazie's taking their whole bridal catalogue circus down to the heart of Florida's citrus country this November. Polk City, mark your calendars for November 14. Now, I'm not the type who usually gets jazzed about gowns and lace, but this pop-up event at Ever After Farms Citrus just might turn a few heads, even...

Continue Reading